ClinicalTrials.Veeva

Menu

Assessing the Efficacy and Impact of Ambient AI Scribes in Healthcare

U

University of Saskatchewan

Status

Not yet enrolling

Conditions

Patient-Phyisican Interaction
Physician Burnout
Physician Workload
Use of Ambient AI Scribes

Treatments

Device: Ambient AI Scribe

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this clinical trial is to assess the impacts of ambient AI scribes on the workload and burnout in physicians who see patients in a clinic setting at least twice in a week, as well as the impacts on patient-physician interaction.

The main questions it aims to answer are:

  • What is the impact of ambient AI scribe use on physician workload and burnout?
  • What is the impact of ambient AI scribe use on quality of patient-physician interaction?

Researchers will compare the group of physicians using the ambient AI scribes to the group not using ambient AI scribes to see if there are any significant differences.

Participants randomly assigned to Group A will make use of the AI scribe and participants randomly assigned to Group B will not use any AI scribe for the 10 working day duration of the study. They will be asked to complete a survey assessing workload and burnout immediately prior to the commencement of the study and at the end of each week of the study or 5 full working days for part time physicians. They will also invite their patients to complete a survey assessing their experience after each clinical interaction.

Enrollment

64 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Physicians from family medicine or any specialty
  • Physicians who regularly see patients in a clinic setting at least 2 days per week

Exclusion criteria

  • Physicians who are planning to leave their practice during the study period

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups

Ambient AI Scribe Users
Experimental group
Description:
This group will make use of the ambient AI scribe in their clinical visits to generate clinical notes for them over the duration of the study.
Treatment:
Device: Ambient AI Scribe
Non-Ambient AI Users
No Intervention group
Description:
This group will continue to generate their own clinical notes without the use of ambient AI scribes over the duration of the study.

Trial contacts and locations

0

Loading...

Central trial contact

Sundus Zia; Scott Adams, MD, PhD, MEd, FRCPC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems